The Preuss Foundation Interleukin-2/LAK Cell Treatment of Brain Tumors Seminar I
June 10, 1987
Dallas, Texas
Gale A. Granger, Ph.D.
University of California, Irvine
Irvine, California
Elizabeth A. Grimm, Ph.D.
University of Texas System Cancer Center
Houston, Texas
Marylou Ingram, M.D.
Huntington Medical Research Institute
Pasadena, California
Steven Jacobs, M.D., Ph.D.
Albert Einstein College of Medicine
Bronx, New York
Mr. Brent Jorgeson
Healthcare International
Austin, Texas
Paul L. Kornblith, M.D.
Albert Einstein College of Medicine
Bronx, New York
Carol A. Kruse, Ph.D.
University of Colorado
Denver, Colorado
Maria Kuppner, Ph.D.
University Hospital, Chuv
Lausanne, Switzerland
Kevin O. Lillehei, M.D.
University of Colorado Health Science Center
Denver, Colorado
M. Stephen Mahaley, Jr., M.D., Ph.D. - Chairperson
University of Alabama
Birmingham, Alabama
Randall E. Merchent, Ph.D.
Virginia Commonwealth University
Richmond, Virginia
Richard P. Moser, M.D.
M.D. Anderson Hospital and Tumor Institute
Houston, Texas
Robert G. Peterson, M.D.
Children’s Hospital
Boston, Massachusetts
Mark Rosenblum, M.D.
University of California, San Francisco
San Francisco, California
Harold F. Young, M.D.
Virginia Commonwealth University
Richmond, Virginia